INS and type 1 diabetes mellitus: Notably, one T1D patient receiving cell therapy with SC-β cells developed by Vertex (VX-880) demonstrated robust insulin secretion from the transplant, improved glycemic control and decreased exogenous daily insulin use (up to a 91% decrease on Day 90 post-transplantation)62.